Expression of DNA repair gene Ku80 in lymphoid neoplasm

European Journal of Haematology

Volumn 74, Issue 6, 2005, Pages 481-488

  Chen, Tsai Yun ^a   Chen, Jiann Shiuh ^a   Su, Wu Chou ^a   Wu, Ming Shiuan ^a   Tsao, Chao Jung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute lymphoblastic leukemia; Ku80; Lymphoproliferative disorders

Indexed keywords

DOUBLE STRANDED DNA; KI 67 ANTIGEN; RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVE SITE; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INFANT; KU70 GENE; KU80 GENE; LABELING INDEX; LEUKOCYTE COUNT; LYMPHATIC SYSTEM TUMOR; LYMPHOPROLIFERATIVE DISEASE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; ANTIGENS, NUCLEAR; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DNA REPAIR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INFANT; KI-67 ANTIGEN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER;

EID: 18844376898     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00428.x     Document Type: Article

References (29)

1. MIMORI T, OHOSONE Y, HAMA N, SUWA A, AKIZUKI M, HOMMA M, GRIFFITH AJ, HARDIN JA. Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome. Proc Natl Acad Sci USA 1990;87:1777-1781.
2. FALZON M, FEWELL JW, KUFF EL. EBP-80, a transcription factor closely resembling the human autoantigen Ku, recognizes single- to double-strand transitions in DNA. J Biol Chem 1993;268:10546-10552.
3. BLIER PR, GRIFFITH AJ, CRAFT J, HARDIN JA. Binding of Ku protein to DNA. Measurement of affinity for ends and demonstration of binding to nicks. J Biol Chem 1993;268:7594-7601.
4. SUWA A, HIRAKATA M, TAKEDA Y, JESCH SA, MIMORI T, HARDIN JA. DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double-stranded DNA. Proc Natl Acad Sci USA 1994;91:6904-6908.
5. GOTTLIEB TM, JACKSON SP. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 1993;72:131-142.
6. CASELLAS R, NUSSENZWEIG A, WUERFFEL R, PELANDA R, REICHLIN A, SUH H, QIN XF, BESMER E, KENTER A, RAJEWSKY K, NUSSENZWEIG MC. Ku80 is required for immunoglobulin isotype switching. EMBO J 1998;17:2404-2411.
7. NUSSENZWEIG A, CHEN C, DA COSTA SOARES V, SANCHEZ M, SOKOL K, NUSSENZWEIG MC, LI GC. Requirement for KuSO in growth and immunoglobulin V(D)J recombination. Nature 1996;382:551-555.
8. VAMVAKAS S, VOCK EH, LUTZ WK. On the role of DNA double-strand breaks in toxicity and carcinogenesis. Crit Rev Toxicol 1997;27:155-174.
9. DIBIASE SJ, ZENG ZC, CHEN R, HYSLOP T, CURRAN WJ Jr, ILIAKIS G. DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res 2000;60:1245-1253.
10. MULLER C, CHRISTODOULOPOULOS G, SALLES B, PANASCI L. DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards. Blood 1998;92:2213-2219.
11. DIFILIPPANTONIO MJ, ZHU J, CHEN HT, MEFFRE E, NUSSENZWEIG MC, MAX EE, RIED T, NUSSENZWEIG A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000;404:510-514.
12. KIM SH, KIM D, HAN JS, JEONG CS, CHUNG BS, KANG CD, LI GC. Ku autoantigen affects the susceptibility to anticancer drugs. Cancer Res 1999;59:4012-4017.
13. BOULTON SJ, JACKSON SP. Identification of a Saccharomyces cerevisiae Ku80 homologue: roles in DNA double strand break rejoining and in telomeric maintenance. Nucleic Acids Res 1996;24:4639-4648.
14. MUNOZ P, ZDZIENICKA MZ, BLANCHARD JM, PIETTE J. Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle. Mol Cell Biol 1998;18:5797-5808.
15. MOSHOUS D, PANNETIER C, CHASSEVAL RD R, DEIST FL F, CAVAZZANA-CALVO M, ROMANA S, MACINTYRE E, CANIONI D, BROUSSE N, FISCHER A, CASANOVA JL, VILLARTAY JP. ParitalT andB lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest 2003;111:381-387.
16. BADIE C, ILIAKIS G, FORAY N, ALSBEIH G, PANTELLIAS GE, OKAYASU R, CHEONG N, RUSSELL NS, BEGG AC, ARLETT CF. Defective repair of DNA double-strand breaks and chromosome damage in fibroblasts from a radiosensitive leukemia patient. Cancer Res 1995;55:1232-1234.
17. MULLER C, SALLES B. Regulation of DNA-dependent protein kinase activity in leukemic cells. Oncogene 1997;15:2343-2348.
18. KLEIN A, MIERA O, BAUER O, GOLFIER S, SCHRIEVER F. Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair. Leukemia 2000;14:40-46.
19. TAI YT, TEOH G, LIN B, DAVIES FE, CHAUHAN D, TREON SP, RAJE N, HIDESHIMA T, SHIMA Y, PODAR K, ANDERSON KC. Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage. J Immunol 2000;165:6347-6355.
20. TSAI SJ, WILTBANK MC. Quantification of mRNA using competitive RT-PCR with standard-curve methodology. Biotechniques 1996;21:862-866.
21. WANG J, DONG X, REEVES WH. A model for Ku heterodimer assembly and interaction with DNA. Implications for the function of Ku antigen. J Biol Chem 1998;273:31068-31074.
22. UM JH, KANG CD, LEE BG, KIM DW, CHUNG BS, KIM SH. Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance. Oncogene 2001;20:6048-6056.
23. KINZLER KW, VOGELSTEIN B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997;386:761-763.
24. LI G, NELSEN C, HENDRICKSON EA. Ku86 is essential in human somatic cells. Proc Natl Acad Sci USA 2002;99:832-837.
25. MULLER C, DUSSEAU C, CALSOU P, SALLES B. Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein. Oncogene 1998;16:1553-1560.
26. MULLER C, MONFERRAN S, GAMP AC, CALSOU P, SALLES B. Inhibition of Ku heterodimer DNA end binding activity during granulocytic differentiation of human promyelocytic cell lines. Oncogene 2001;20:4373-4382.
27. HAN Z, JOHNSTON C, REEVES WH, CARTER T, WYCHE JH, HENDRICKSON EA. Characterization of a Ku86 variant protein that results in altered DNA binding and diminished DNA-dependent protein kinase activity. J Biol Chem 1996;271:14098-14104.
28. CAI QQ, PLET A, IMBERT J, LAFAGE-POCHITALOFF M, CERDAN C, BLANCHARD JM. Chromosomal location and expression of the genes coding for Ku p70 and p80 in human cell lines and normal tissues. Cytogenet Cell Genet 1994;65:221-227.
29. BEILLARD E, PALLISGAARD N, VAN DER VELDEN VH, BI W, DEE R, VAN DER SCHOOT E, DELABESSE E, MACINTYRE E, GOTTARDI E, SAGLIO G, WATZINGER F, LION T, van DONGEN JJ, HOKLAND P, GABERT J. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 2003;17:2474-2486.